![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Abbvie IFN-free 3 DAA Regimen in HCV Genotype 1-infected Pati ents on Methadone or Buprenorphine
|
|
|
Reported by Jules Levin
Presented at the 21st Annual Conference on Retroviruses and Opportunistic Infections, March 3-6, 2014, Boston, Massachusetts
Jacob Lalezari1, J Greg Sullivan2, Vinod Rustgi3, Humberto Aguilar4, Franco Felizarta5, Daniel Cohen6
1Quest Clinical Research, San Francisco, California, United States; 2Parkway Medical Center, Birmingham, Alabama, United States; 3Metropolitan Research, Fairfax, Virginia, United States; 4Louisiana Research Center, LLC, Shreveport, Louisiana, United States; 5Private practi ce, Bakersfi eld, California, United States; 6AbbVie Inc., North Chicago, Illinois, United States
![CROI1.gif](../images/030614/030614-2/CROI1.gif)
![CROI2.gif](../images/030614/030614-2/CROI2.gif)
![CROI3.gif](../images/030614/030614-2/CROI3.gif)
![CROI4.gif](../images/030614/030614-2/CROI4.gif)
![CROI5.gif](../images/030614/030614-2/CROI5.gif)
![CROI6.gif](../images/030614/030614-2/CROI6.gif)
![CROI7.gif](../images/030614/030614-2/CROI7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|